TILDRAKIZUMAB-ASMN for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

There are 879 adverse event reports in the FDA FAERS database where TILDRAKIZUMAB-ASMN was used for Psoriasis.

Most Reported Side Effects for TILDRAKIZUMAB-ASMN

Side Effect	Reports	%	Deaths	Hosp.
Product dose omission issue	363	22.4%	4	10
Drug ineffective	223	13.8%	0	2
Psoriasis	86	5.3%	0	3
Death	84	5.2%	84	1
Product storage error	74	4.6%	0	0
Self-medication	74	4.6%	0	0
Off label use	66	4.1%	2	0
Condition aggravated	63	3.9%	0	2
Rash	54	3.3%	1	1
Pruritus	52	3.2%	0	1
Therapy cessation	50	3.1%	0	3
Inappropriate schedule of product administration	41	2.5%	0	2
Diarrhoea	36	2.2%	0	3
Circumstance or information capable of leading to medication error	35	2.2%	0	0
Product administration error	24	1.5%	0	1